拉莫三嗪治疗发作性运动诱发性运动障碍14例临床疗效观察  

The clinical study on effects of lamotringine in treating 14 patients with paroxymal kinesigenic dyskinesia

作　　者：郑乃智[1] 王敏[1] 宋旭霞[1] 卢幸明[1] 

机构地区：[1]青岛大学医学院附属青岛市市立医院神经科,山东青岛266011

出　　处：《临床神经电生理学杂志》2009年第2期84-86,共3页Journal of Clinical Electroneurophysiology

摘　　要：目的：研究拉莫三嗪（LTG）治疗发作性运动诱发性运动障碍（PKD）14例的临床疗效。方法：结合门诊随访和电话回访，复习14例PKD患者应用LTG的治疗情况。结果：LTG治疗PKD患者有效率为100％。LTG平均用量（63．9±30．4）mg／d。结论：LTG治疗PKD患者有效率较高，且所用LTG剂量较作为常规抗癫痫药物时的剂量小。Objective;To study the clinical effects of lamotrigine（LTG） in treating 14 cases of paroxymal kinesigenic dyskinesia（PKD）. Methods： We reviewed LTG clinical treatment of 14 patients with PKD and paid a return visit by telephone. Results： The effective ratio of LTG in treating patients with PKD was 100 %. The average dosage of LTG was（63.9 ± 30.4）mg/day. Conclusions： The effective ratio of LTG in treating patients with PKD is very high. The average dosage of LTG is less than in convention ally treating epilepsy.

关 键 词：拉莫三嗪(LTG) 发作性运动诱发性运动障碍(PKD) 

分 类 号：R742.89[医药卫生—神经病学与精神病学] R971.6[医药卫生—临床医学]